MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

ORIC — Oric Pharmaceuticals, Inc. Common Stock

Nasdaq

Oric Pharmaceuticals, Inc. Common Stock

CompareBack to Screener
$12.01
+0.03(+0.25%)
O
11.83
H
12.43
L
11.81
V
790.76K
⏱️ End-of-day dataAs of Oct 7, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About ORIC

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 24, 2020
Employees111
Stock ExchangeNasdaq
Ticker SymbolORIC
Websitehttps://www.oricpharma.com

Key Financial Statistics

Market Cap$1.27B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$7.23 - $14.93
52-Week Avg Volume1.61M
VWAP$12.11
Transactions11,789
Total Recorded Bars1,622 days